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The effects of hypoxia on gene expression have been vigorously studied, but possible effects of small
changes in oxygen tension have never been addressed. SUR2A is an atypical ABC protein serving as a regu-
latory subunit of sarcolemmal ATP-sensitive K+ (KATP) channels. Up-regulation of SUR2A is associated with
cardioprotection and improved physical endurance. Here, we have found that a 24 h-long exposure to
slightly decreased ambient fractional concentration of oxygen (20% oxygen), which is an equivalent to ox-
ygen tension at 350 m above sea level, significantly increased levels of SUR2A in the heart despite that this
drop of oxygen did not affect levels of O2, CO2 and hematocrit in the blood or myocardial levels of ATP, lac-
tate and NAD/NADH/NAD+. Hearts from mice exposed to 20% oxygen were significantly more resistant to
ischaemia-reperfusion when compared to control ones. Decrease in fractional oxygen concentration of
just 0.9% was associated with phosphorylation of ERK1/2, but not Akt, which was essential for up-
regulation of SUR2A. These findings indicate that a small drop in oxygen tension up-regulates SUR2A in
the heart by activating ERK signaling pathway. This is the first report to suggest that a minimal change in
oxygen tension could have a profound signaling effect.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
SUR2A belongs to a group of “atypical” ABC proteins as, although
possessing a structure of an ABC protein, it does not seem to mediate
transport [1]. SUR2A is known to bind to inward rectifier Kir6.2 to
form ATP-sensitive K+ (KATP) channels in the heart. The binding of
SUR2A to Kir6.2 serves a dual purpose: 1) it allows translocation of
the channel to the sarcolemma and 2) contributes to the channel regu-
lation [2]. ATP-sensitive K + (KATP) channels were originally described
in cardiomyocytes, where they exert a cardioprotective role during
metabolic stress. Up-regulation of myocardial SUR2A expression
increases the number of fully-assembled KATP channels and induces
range of effects including an increase in myocardial resistance towards
metabolic stress [3,4], an increase in physical endurance [5], prevention
of aging-induced physical decline [6] and shifting cardiomyocytes
towards less differentiated state [7]. Signaling factors/pathways and
conditions regulating levels of SUR2A are not yet fully understood. It
has been shown that young age, female gender, nicotinamide-rich diet
and exercise are associated with increased levels of SUR2A in the
heart. These effects seem to be mediated by changes in estrogen and
NAD/NADH levels [6,8–12].
In heart embryonic H9c2 cell line exposure to 13% hypoxia up-
regulates SUR2A, without affecting expression of any other gene [13].
It is well established that hypoxia induces a range of effects and regu-
lates expression of different genes [14], but the effects of hypoxia
in vivo are usually observed at fractional concentration of oxygen
below 15% [15,16]. Effects of more modest changes in oxygen tension
on gene expression have been rarely investigated. In fact, there is no
study so far that investigated effects of small changes in oxygen tension
on gene expression.
Taking into account that in vitro experiments suggested that SUR2A
is uniquely sensitive to hypoxia,we have looked into possible regulation
of SUR2A in the heart by slightly decreased oxygen tension. We have
exposed animals to 20% oxygen, which is equivalent to oxygen tension
at ~350 m above sea level, and found that this activated a major signal-
ing pathway and had a profound effect on expression of SUR2A. Such
effect of seemingly negligible change in oxygen has never been previ-
ously described.
2. Materials and methods
2.1. In vivo exposure ofmice to different fractional concentrations of oxygen
C57BL/6Jmalemice (6–8 weeks old)were exposed to either ambient
oxygen (detected to be 20.9%) or fractional concentration of oxygen of
20% oxygen using integral Animal Hypoxia Chamber System; oxygen
levels were controlled by ProOx Model 110 version 2.2 (Biospherix,
Lacona, NY, USA). The ProOx P110 senses oxygen inside the chamber
and infuses either nitrogen to lower the concentration or oxygen to
raise it. Mice, in groups of 5, were placed in a chamber for 24 h in either
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20.9% or 20% oxygen, which level was continuously monitored. All
handling of mice was done inside the chamber. Some animals were
injected i.p. with inhibitor of ERK1/2, U0126 (2 μg/mouse; volume was
200 μl and vehicle was saline; Sigma-Aldrich, Gillingham, UK). 30 min
after the injection animalswere introduced into the chamber. For this se-
ries of experiments, control animals were injected with only vehicle (ie.
200 μl of saline i.p. injection) and subjected to the same protocol as
U0126-treated animals. The experiments have been done under author-
ity of Project License 60/3925.
2.2. Blood gas and hematocrit analysis
Blood gas (PO2 andPCO2) and hematocrit weremeasured in samples
(500–700 μl) taken directly from the heart using pre-heparinized
(1000 IU/ml) syringes and Rapidlab 348EX blood Gas System (Siemens,
Frimley, UK).
2.3. Measurement of ATP in the heart
ATP concentration in heart tissue lysates was measured using
luciferase-based ATP determination kit (Invitrogen, Paisley, UK) accord-
ing to the manufacturer's instructions. Luminescence was measured at
560 nm using microplate reader/multidetection reader (SPECTRAMAX
M2, Molecular Devices, Wokingham, UK).
2.4. Measurement of NAD/NADH in the heart
NAD/NADH was measured in heart tissue using NAD/NADH kit
(Abcam, Cambridge, UK) according to the manufacturer's instruc-
tion. Absorbance was measured at 450 nm using microplate reader/
multidetection reader (SPECTRAMAX M2, Molecular Devices,
Wokingham, UK). Total NAD (NADt) and NADH were estimated di-
rectly while the value of NAD+ was estimated by subtracting NADH
from NADt.
2.5. Measurement of lactate in the heart
Lactate was measured in heart tissue lysates using ADVIA Chemistry
Lactate Enzymatic Assay and ADVIA Chemistry System 1200 (Siemens,
Frimley, UK). Lactate is oxidized by lactate oxidase to pyruvate and
hydrogen peroxide and it was measured by the formation of dye from
hydrogen peroxide and a chromogen in the presence of a peroxidase.
Absorbance was measured at 545/694 nm.
2.6. Ischaemia-reperfusion and measurement of creatine kinase (CK) and
lactate dehydrogenase (LDH)
Ischaemia-reperfusion of hearts was performed as described in ref.
[10] and perfusate was recirculated during reperfusion and collected at
the end of this stage. CK and LDH in perfusates from the hearts
exposed ischaemia-reperfusion were measured using ADVIA Chemistry
System 2400 (Siemens, Frimley, UK). CK reacts with creatine phosphate
and ADP to form ATP which is coupled to the hexokinase-G6PD reaction,
generating NADPH. The concentration of NADPH as a measure of CK
activity was determined by changes in absorbance at 340/410 nm. LDH
catalyzes the conversion of lactate to pyruvate in the presence of NAD.
The enzymatic activity of lactate dehydrogenase is proportional to the
rate of production of NADH. The amount of NADH produced is deter-
mined at 340/410 nm.
2.7. Western blotting
ForWestern blottingheartswere harvested and snap-frozen andho-
mogenized in lysis buffer (50 mM Tris–HCl, pH 7.5; 1 mM EDTA; 1 mM
EGTA; 1% (w/v) Triton X-100; 0.1% (v/v)—mercaptoethanol; 1 mM so-
dium orthovanadate; 50 mM sodium fluoride; 5 mM sodium
pyrophosphate; 1 μMmicrocystin-LR; and one tablet of “complete” pro-
teinase inhibitor per 50 ml of buffer). A 10-fold mass excess of ice-cold
lysis buffer was added to the powdered.
Tissue, briefly vortexed, and then centrifuged at 4 °C for 10min at
13,000 g to remove insoluble material. The supernatant was snap-
frozen in aliquots in liquid nitrogen and stored at −80 °C. Protein
concentration was determined by Bradford Assay. From each sample,
20 μg of protein was subjected to SDS/PAGE and transferred to nitro-
cellulose. For all blots, the nitrocellulose membranes were incubated
at 4 °C for 16 h using the antibodies against SUR2A, Kir6.2 (both from
Santa Cruz Biotechnology, Heidelberg, Germany), Akt total antibody,
total ERK1/2 antibody, phospho-Akt antibodies (Thr308 and Ser473)
and phospho-ERK1/2 (all from Millipore, Watford, UK). All antibod-
ies were applied in 1:1000 dilution. The blots were incubated in
50 mM Tris/HCl, pH 7.5; 0.15 M NaCl; and 0.2% (by vol) Tween con-
taining 5% (by mass) skimmed milk. Detection of total or phosphor-
ylated protein was performed using horse radish peroxidase
conjugated secondary antibodies (Pierce, Rockford, IL, USA) and en-
hanced chemiluminescence (ECL) reagent (Upstate, Dundee, UK). All
antibodies have been characterized in details. SUR2A antibody pro-
duced a single signal in the expected region (Fig. 1). The Kir6.2 anti-
body produced several signals, but one of those was 39 kDa, which is
the exact size of Kir6.2 (Fig. 1). Antibodies against ERK1/2, phospho-
ERK1/2, Akt, S473 phospho-Akt and T308 phospho-Akt yielded soli-
tary or double signals (where appropriate) in expected regions
(Fig. 1). The band intensities were analyzed using Quantiscan soft-
ware (Cambridge, UK).
2.8. Statistical analysis
Data are presented as mean±S.E.M., with n representing the
number of analyzed mice or cells. Mean values were compared by
Student's t-test using SigmaStat program (Jandel Scientific, Chicago,
Illinois). P b 0.05 was considered statistically significant.
3. Results
3.1. 24 h-long exposure to 20% oxygen does not induce hypoxia in mice, but
it up-regulates SUR2A in the heart
Mice were exposed to either 20.9% air oxygen or 20% oxygen. Oxygen
tension in the blood was slightly decreased in mice exposed to 20% oxy-
gen, but the difference was not statistically significant (P = 0.365;
Fig. 2). No differences were found in blood partial pressure of CO2 (P =
0.753; Fig. 2). Also, hematocrit did not differ between experimental
groups (P = 0.723; Fig. 2). In hearts, no differences were observed be-
tween NAD levels (NADt: P = 0.196; NADH: P = 0.772, Fig. 2). Small
changes in oxygen tension also did not affect levels of ATP (P =
0.724; Fig. 2) and lactate (P= 0.09; Fig. 2). However, such seemingly
negligible change in oxygen induced a substantial increase in SUR2A
in the myocardium (Fig. 2; P = 0.001), while the expression
of another KATP channel forming subunit, Kir6.2, was not affected
(P = 0.281; Fig. 2).
An increase in SUR2A in the heart is a significant signaling event
with major implications: it increases heart resistance to ischaemia-
reperfusion [10], counteracts aging-induced increase in myocardial
susceptibility to stress [6] and promotes stem cells properties of
cardiomyocytes [7]. We have tested whether exposure to 20% oxy-
gen would affect myocardial resistance to ischaemia-reperfusion by
measuring amounts of CK and LDH released from the muscle during
this challenge, which is a good indication of necrosis of the myocar-
dium. We have found that hearts from animals exposed to 20% oxy-
gen released significantly less CK and LDH than animals exposed to
20.9% oxygen (CK: P = 0.019; LDH = 0.038; Fig. 3).
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3.2. 24 h-long exposure to 20% oxygen activates ERK, but not Akt in the
heart
Phosphatidylinositol-4,5-bisphosphate 3-kinases (PI3K) are family
of enzymes involved in crucial cell physiological functions including
the cell survival. Most of PI3K functions are related to its ability to acti-
vate Akt, also known as protein kinase B (PKB) [17,18]. Activation of Akt
is a crucial signaling event in evoking cardioprotection [17,19,20]. Thus,
we have examined a possible link between Akt and SUR2A. Antibodies
targeting phosphorylation of Akt at S473 and T308 sites were used as
well as an antibody targeting Akt non-selectively. We have found that
exposure to 20% oxygen did not phosphorylate Akt either on S473 or
on T308 (Fig. 4).
Extracellular signal regulated kinases (ERK1/2) are ubiquitously
expressed and are involved in regulation of important physiological
processes including cellular differentiation, proliferation, survival and
others. ERK1/2 can be stimulated by a number of factors including
growth factors, cytokines, G protein-regulated receptors and viral infec-
tions [21,22]. Here, we have tested whether phosphorylation of ERK1/2
occurs during exposure to 20% oxygen. Exposure to 20% oxygen signif-
icantly increased signal for both ERK1 and ERK2 (ERK1: P b 0.01; ERK2:
P b 0.01; Fig. 5). The ratio phospho vs total ERK was significantly in-
creased for both ERK1 (P = 0.018; Fig. 4) and ERK2 (P b 0.001; Fig. 5).
3.3. Activation of ERK is responsible for up-regulation of SUR2A in the heart
induced by 24 h-long exposure to 20% oxygen
ERK1/2 activation could have been epiphenomenon that is not relat-
ed to regulation of SUR2A at all. In order to find out a causal relationship
between ERK activation and SUR2A, we have treated animals with
U0126 (2 μg/mouse), an inhibitor of ERK1/2 phosphorylation [19].
When U0126-treated animals exposed to 20% oxygen were compared
with vehicle-treated animals exposed to 20.9% oxygen, no differences
in ERK1/2 phosphorylation was observed between groups (ERK1: P =
0.538; ERK2: P = 0.517; Fig. 6). The ratio phospho vs total ERK was
not changed for both ERK1 (P = 0.710; Fig. 6) and ERK2 (P = 0.612;
Fig. 5). At the same time, treatment with U0126 prevented increase in
myocardial SUR2A in mice exposed to 20% oxygen (Fig. 6; P = 0.496).
4. Discussion
Cardiac response to chronic hypoxia has been studied in details due
to reports suggesting that high-altitude residents have lower mortality
rates for ischaemic heart disease [23–25]. In agreement with these re-
ports were findings that exposure to moderate hypoxia confers
cardioprotection in experimental animals [26,27]. It has been suggested
that this is due to myocardial metabolic reorganization and increase in
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signals appearing on blots. Typical examples of original Western blots obtained in this study.
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utilization of carbohydrates as cardiac fuel substrate (versus fatty acids)
and augmentedmitochondrial respiratory capacity [30]. Metabolic gene
remodeling in response to hypoxia has also been reported [28]. It has
been already shown that under in vitro conditions mild hypoxia up-
regulates SUR2A in rat heart embryonic H9c2 line creating cellular phe-
notype resistant to metabolic stress [13]. What was interesting in this
study was finding that SUR2A was the only gene regulated by the
level of hypoxia applied [13]. However, hypoxia applied in that study al-
tered NAD+/NADH ratio, which was required for up-regulation of
SUR2A [13]. In the present study, a slight decrease in concentration of
oxygen was not associated with usual signs of hypoxia in the blood or
myocardium. In hypoxia, NAD+/NADH ratio changes, levels of ATP
and lactate decrease and increase respectively [29,30]. Exposure to
20% oxygen did not affect neither cardiac NAD+/NADH levels nor levels
of ATP or lactate suggesting a possibility that heart was not exposed to
hypoxia irrespective to systemic exposure of mice to slightly decreased
oxygen tension. This is probably not unexpected as a drop of 0.9% oxy-
gen seems to be minimal.
However, such small decrease in oxygen tension up-regulated
SUR2A. In vitro exposure to 13% oxygen altered NAD+/NADH levels
which was shown to regulate expression of SUR2A [5,10,13]. However,
in mice exposed to 20% oxygen we did not find signs that their hearts
were subjected to hypoxia, and yet SUR2A was increased. An increase
of SUR2A was shown to protect myocardium against ischaemia-
reperfusion [3,10] as well as adult and embryonic cardiomyocytes
against different types of metabolic stresses [3–6]. A range of diverse
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conditions such as young age, female gender, nicotinemide-rich diet
and acute and chronic exercise [8–12] were associated with increased
SUR2A levels and cardioprotection. Increase of SUR2A alone is sufficient
to confer cardioprotection even if Kir6.2 levels remain unchanged [3–5,
8]. Themechanism of cardioprotection afforded by SUR2A alone is com-
plex and seems to involve activity-dependent and activity-independent
properties of KATP channels [3–5,7,31,32]. CK and LDH are well
established markers of myocardial injury [33], and we have used them
here to determinewhether exposure to 20% oxygen increases resistance
to ischaemia-reperfusion. Indeed, exposure to 20% oxygen decreased
the amounts of CK and LDH released from myocardium in response to
ischaemia-reperfusion suggesting an increase in myocardial resistance
to injury. These results fit very well with the notion that 20% oxygen in-
creases levels of SUR2A in the heart, which in turn confers
cardioprotection.
PI3K/Akt cascade is a major signaling pathway mediating
cardioprotection [18,19]. Taking into consideration that SUR2A confers
cardioprotection, a link between Akt and SUR2A expression was exam-
ined in this study. We have found that exposure to 20% oxygen did not
phosphorylate Akt either on S473 or on T308, excluding a possibility
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that activation of Akt is required for up-regulation of SUR2A induced by
slight drop in oxygen tension.
It has been previously shown thatmild hypoxia activates ERK to reg-
ulate expression of SUR2A in embryonic rat heart H9c2 cell line [13]. In
embryonic hearts increase in SUR2A levels shifts cardiomyocytes to-
wards less differentiated state by inhibiting ERK1/2 [7]. Here, we have
found that exposure to 20% oxygen was associated with phosphoryla-
tion of ERK1/2. U0126 inhibited both phosphorylation of ERK1/2 and in-
crease in SUR2A induced by 20% oxygen. Taking all together, it is clear
that exposure to 20% oxygen activates ERK1/2 and that this activation
is required for up-regulation of SUR2A and cardioprotection. It has
been previously shown that ERK regulates expression of SUR2A via c-
jun and regulation of SUR2 promoter activity [13]. However, it remains
unclear what activates ERK1/2 in the heart of animals exposed to 20%
oxygen. In H9c2 cells it has been proposed that mild hypoxia changes
NAD+/NADH ratio and that this act as a trigger for signaling cascade
involving ERK and SUR2A [13]. Again, a drop of only ~1% in oxygen con-
centration did not affect NAD+/NADH ratio showing that something
else is responsible for ERK1/2 phosphorylation and consequent increase
in SUR2A levels. How ERK in the heart is activated by a small decrease of
oxygen tension in vivo remains to be established. At the moment, it is
difficult to speculate about sequence of events leading to ERK activation
and SUR2A up-regulation as oxygen sensor responding to such small
change to oxygen tension is yet unknown.
4.1. Limitations of the study
This study has demonstrated that even very small changes in oxygen
tension induce a significant signaling response. However, this study has
some limitations. Themajor limitation is that all parameters were mea-
sured at one time point (24 h), meaning that we could have missed an
important early signaling event (changes in NAD/NADH ratio as an
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example). Also, we did not assess contributions of various signaling fac-
tors that could have been involved. There are also other limitations that
are present in almost every study such as species (mice) and gender
(males alone) used.
5. Conclusion
Taken all together, we have shown in this study that a seemingly
negligible decrease in oxygen tension in vivo activates ERK1/2 to up-
regulate SUR2A. This is a first demonstration of a gross signaling effect
induced by a small change in oxygen tension.
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